These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28017552)

  • 1. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Alvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Cammafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Hipertens Riesgo Vasc; 2017; 34(1):24-40. PubMed ID: 28017552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Álvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; de Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Gac Sanit; 2017; 31(3):255-268. PubMed ID: 28292529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Álvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; de Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Semergen; 2017; 43(4):295-311. PubMed ID: 28532894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice.
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Alvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Clin Investig Arterioscler; 2017; 29(2):69-85. PubMed ID: 28173956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spanish Adaptation of the 2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice].
    Royo-Bordonada MA; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Álvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Rev Esp Salud Publica; 2016 Nov; 90():e1-e24. PubMed ID: 27880755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.
    Armario P; Brotons C; Elosua R; Alonso de Leciñana M; Castro A; Clarà A; Cortés O; Díaz Rodriguez Á; Herranz M; Justo S; Lahoz C; Pedro-Botet J; Pérez Pérez A; Santamaria R; Tresserras R; Aznar Lain S; Royo-Bordonada MÁ
    Clin Investig Arterioscler; 2021; 33(2):85-107. PubMed ID: 33495044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines].
    Royo-Bordonada MA; Lobos Bejarano JM; Villar Alvarez F; Sans S; Pérez A; Pedro-Botet J; Moreno Carriles RM; Maiques A; Lizcano A; Lizarbe V; Gil Núñez A; Fornés Ubeda F; Elosua R; de Santiago Nocito A; de Pablo Zarzosa C; de Álvaro Moreno F; Cortés O; Cordero A; Camafort Babkowski M; Brotons Cuixart C; Armario P;
    Clin Investig Arterioscler; 2013; 25(3):127-39. PubMed ID: 23726872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention].
    Brotons C; Camafort M; Del Mar Castellanos M; Clarà A; Cortés O; Diaz Rodriguez A; Elosua R; Gorostidi M; Hernández AM; Herranz M; Justo S; Lahoz C; Niño P; Pallarés-Carratalá V; Pedro-Botet J; Pérez Pérez A; Royo-Bordonada MA; Santamaria R; Tresserras R; Zamora A; Zuza I; Armario P
    Hipertens Riesgo Vasc; 2022; 39(2):69-78. PubMed ID: 35331672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.
    Brotons C; Camafort M; Castellanos MDM; Clarà A; Cortés O; Diaz Rodríguez Á; Elosua R; Gorostidi M; Hernández AM; Herranz M; Justo S; Lahoz C; Niño P; Pallarés-Carratalá V; Pedro-Botet J; Pérez Pérez A; Royo-Bordonada MÁ; Santamaría R; Tresserras R; Zamora A; Zuza I; Armario P
    Nefrologia (Engl Ed); 2023; 43(3):360-369. PubMed ID: 37635013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention.
    Brotons C; Camafort M; Castellanos MDM; Clarà A; Cortés O; Diaz Rodriguez A; Elosua R; Gorostidi M; Hernández AM; Herranz M; Justo S; Lahoz C; Niño P; Pallarés-Carratalá V; Pedro-Botet J; Pérez Pérez A; Royo-Bordonada MA; Santamaria R; Tresserras R; Zamora A; Zuza I; Armario P
    Clin Investig Arterioscler; 2022; 34(4):219-228. PubMed ID: 35906022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines].
    Armario P; Brotons C; Elosua R; Alonso de Leciñana M; Castro A; Clarà A; Cortés O; Díaz Rodriguez Á; Herranz M; Justo S; Lahoz C; Pedro-Botet J; Pérez Pérez A; Santamaria R; Tresserras R; Aznar Lain S; Royo-Bordonada MÁ
    Hipertens Riesgo Vasc; 2021; 38(1):21-43. PubMed ID: 33069629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines.
    Royo-Bordonada MA; Lobos Bejarano JM; Villar Alvarez F; Sans S; Pérez A; Pedro-Botet J; Moreno Carriles RM; Maiques A; Lizcano Á; Lizarbe V; Gil Núñez A; Fornés Ubeda F; Elosua R; de Santiago Nocito A; de Pablo Zarzosa C; de Álvaro Moreno F; Cortés O; Cordero A; Camafort Babkowski M; Brotons Cuixart C; Armario P;
    Neurologia; 2016 Apr; 31(3):195-207. PubMed ID: 23969295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.].
    Armario P; Brotons C; Elosua R; Alonso de Leciñana M; Castro A; Clarà A; Cortés O; Díaz Rodriguez Á; Herranz M; Justo S; Lahoz C; Pedro-Botet J; Pérez Pérez A; Santamaria R; Tresserras R; Aznar Lain S; Royo-Bordonada MÁ
    Rev Esp Salud Publica; 2020 Sep; 94():. PubMed ID: 32915170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC) on the 2012 European Cardiovascular Prevention Guidelines].
    Royo-Bordonada MÁ; Lobos Bejarano JM; Villar Alvarez F; Sans S; Pérez A; Pedro-Botet J; Moreno Carriles RM; Maiques A; Lizcano A; Lizarbe V; Gil Núñez A; Fornés Ubeda F; Elosua R; de Santiago Nocito A; de Pablo Zarzosa C; de Álvaro Moreno F; Cortés O; Cordero A; Camafort Babkowski M; Brotons Cuixart C; Armario P;
    Rev Esp Salud Publica; 2013; 87(2):103-20. PubMed ID: 23775101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Cardiovascular Risk in Spain by the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice.
    Amor AJ; Masana L; Soriguer F; Goday A; Calle-Pascual A; Gaztambide S; Rojo-Martínez G; Valdés S; Gomis R; Ortega E;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):417-25. PubMed ID: 25444376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease: strategies for risk assessment and modification.
    Braun LT
    J Cardiovasc Nurs; 2006; 21(6 Suppl 1):S20-42; quiz S43-5. PubMed ID: 17293747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; ;
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):913-9. PubMed ID: 25443815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.